Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2009-03-12 Capital/Financing Update
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Appendix 3B 7 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class and number of securities issued, issue price, purpose of the issue, and quotation application to the ASX. It references specific ASX rules and includes sections typical of a new issue announcement such as details on securities ranking, underwriting, and quotation agreements. The document does not contain financial statements or management discussion but is clearly an announcement related to capital raising and issuance of shares. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed issuance information, confirming it is not a mere announcement of a report but the actual issuance notice.
2009-03-12 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules related to new securities issuance and quotation. It details the issuance of ordinary shares, options, and performance rights, including the number of securities, terms, and dates related to allotment and quotation. The document is a formal announcement to the Australian Securities Exchange (ASX) about the new issue of securities and application for quotation. It does not contain financial statements, management discussion, or detailed financial results. It is a regulatory announcement specifically about capital changes and new share issues. Therefore, the document fits the category of 'Share Issue/Capital Change' (SHA). The document length is substantial (10,993 characters), indicating it is not a mere brief announcement or report publication notice but a full regulatory form for new issue announcement.
2009-03-04 English
Form 605 - Ceasing to be a substantial holder 2 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001. It details changes in relevant interests and associations related to substantial shareholding in CSL Limited. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not a financial report, management information, or regulatory announcement unrelated to shareholding. Therefore, the correct classification is MRQ.
2009-03-01 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class, number, terms, issue price, purpose, and quotation application for additional securities. It references ASX rules and includes a quotation agreement section. The content is consistent with a formal announcement of new share issues and related securities information, typical of a capital raising or share issuance announcement. There is no indication of financial statements, management discussion, or audit information. The document is not a report but an announcement related to capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail support a high confidence in this classification.
2009-02-22 English
Change of Directors Interest Notice 14 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in directors' relevant interests in securities, including the number of shares held before and after the change, dates of changes, and consideration paid. The content is focused on reporting personal share transactions by company directors. There is no indication of financial results, management discussion, or other report types. The document is lengthy and contains detailed transaction data, not just an announcement or certification. Therefore, it fits the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades).
2009-02-19 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class, number, terms, issue price, purpose, and quotation application for additional securities. It references ASX rules and compliance with the Corporations Act, indicating it is a formal announcement related to capital changes. The content focuses on the issuance and quotation of new shares and securities, which aligns with announcements about share issues or capital changes. There is no financial performance data, management discussion, or audit information, so it is not an annual or interim report, audit report, or earnings release. The document is not a proxy, voting result, or AGM material. Given the detailed nature of the issuance and quotation information, this fits the category of a Share Issue/Capital Change announcement rather than a general regulatory filing or report publication announcement. Therefore, the correct classification is 'SHA' (Share Issue/Capital Change).
2009-02-18 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.